Gandeeva Therapeutics
Healthcare AI
Drug discovery platform / precision biotechnology
Series A
Gandeeva Therapeutics is a precision biotechnology company that integrates cryogenic electron microscopy, machine learning, and high-resolution molecular imaging to discover and develop therapeutics by targeting difficult protein-protein interactions; it positions its platform around structure-guided drug discovery for precision medicine and lower late-stage clinical failure risk.
Company Details
- Website
- gandeeva.com
- Headquarters
- Vancouver, British Columbia, Canada
- Founded
- 2017
- Funding
- $40M
Subscriber Intelligence
- • Deal signal alerts for this company
- • Sentiment & risk scoring
- • Competitive framework analysis
- • Regulatory event monitoring